Ursapharm India Profile
Key Indicators
- Authorised Capital ₹ 1.25 Cr
as on 07-07-2024
- Paid Up Capital ₹ 1.20 Cr
as on 07-07-2024
- Company Age 18 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -29.82%
(FY 2022)
- Profit -134.40%
(FY 2022)
- Ebitda -56.83%
(FY 2022)
- Net Worth -7.42%
(FY 2022)
- Total Assets -9.80%
(FY 2022)
About Ursapharm India
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.25 Cr and a paid-up capital of Rs 1.20 Cr, as per Ministry of Corporate Affairs (MCA) records.
Uwe Hurth, Boris Roeder, and Rohit Jain serve as directors at the Company.
- CIN/LLPIN
U24232DL2006FTC154392
- Company No.
154392
- Company Classification
Private Limited Foreign Company Incorporated In India
- Incorporation Date
27 Sep 2006
- Date of AGM
26 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
South Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Ursapharm India?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rohit Jain  | Managing Director | 01-Apr-2020 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Uwe Hurth  | Director | 05-Dec-2017 | Current |
| Boris Roeder | Director | 27-Sep-2006 | Current |
Financial Performance of Ursapharm India.
Ursapharm India Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 29.82% decrease. The company also saw a substantial fall in profitability, with a 134.4% decrease in profit. The company's net worth dipped by a decrease of 7.42%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ursapharm India?
In 2019, Ursapharm India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Ibiza Hotels And Real Estate Developers Private LimitedActive 16 years 9 months
Rohit Jain is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ursapharm India?
Unlock and access historical data on people associated with Ursapharm India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ursapharm India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ursapharm India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
